scispace - formally typeset
E

Elizabeth Oldham

Researcher at Merck & Co.

Publications -  21
Citations -  2492

Elizabeth Oldham is an academic researcher from Merck & Co.. The author has contributed to research in topics: C-C chemokine receptor type 6 & Chemokine receptor. The author has an hindex of 11, co-authored 21 publications receiving 2385 citations. Previous affiliations of Elizabeth Oldham include Schering-Plough.

Papers
More filters
Journal ArticleDOI

Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis

TL;DR: C cultured primary keratinocytes, dermal fibroblasts, and dermal microvascular endothelial and dendritic cells are major sources of CCL20, and that the expression of this chemokine can be induced by proinflammatory mediators such as TNF-α/IL-1β, CD40 ligand, IFN-γ, or IL-17 are shown.
Journal ArticleDOI

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

TL;DR: An important role is suggested for CTACK in recruitment of CLA(+) T cells to cutaneous sites and it is suggested that CTACK is predominantly expressed in the skin and selectively attracts a tissue-specific subpopulation of memory lymphocytes.
Journal Article

The CC Chemokine Receptor-7 Ligands 6Ckine and Macrophage Inflammatory Protein-3β Are Potent Chemoattractants for In Vitro- and In Vivo-Derived Dendritic Cells

TL;DR: Using a novel transwell chemotaxis assay system, it is demonstrated that the CC chemokine receptor-7 (CCR7) ligands 6Ckine and macrophage inflammatory protein (MIP)-3β are selective chemoattractants for MHC class IIhigh B7-2high bone marrow-derived dendritic cells at a potency 1000-fold higher than their known activity on naive T cells.